Publications by authors named "Elizabeth Brem"

Claim this Profile
R
R-DA-EPOCH Versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma.
Benjamin J Lee, Shawn P Griffin, Jean Doh, Anthony Quach, Yujiao Sun, Elizabeth A Brem

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.
Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Lauren Pinter-Brown, Elizabeth A Brem, Shawn P Griffin

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent plasma cell myeloma with intracytoplasmic Auer rod-like inclusions after autologous hematopoietic stem cell transplantation.
Chenchen Niu, Elizabeth Brem, Ying Zhang, Dong Ren, Truc Tran

Int J Clin Exp Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysis.
Aaron S Rosenberg, Emanual Maverakis, Caitlin Costello, Elizabeth A Brem, Matthew Joseph Wieduwilt

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Pongthep Vittayawacharin, Benjamin J Lee, Ghayda' E'leimat, Yen Cao, Jack Reid, Elizabeth A Brem

Eur J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy.
Elizabeth A Brem, Kevin Shieh, Dennis Juarez, Roberta Buono, Deepa Jeyakumar

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.
Benjamin J Lee, Jenny Liu, Shawn P Griffin, Jean Doh, Stefan O Ciurea, Elizabeth A Brem

Cancer Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS prophylaxis is (mostly) futile in DLBCL.
Kevin Shieh, Elizabeth Brem

BJC Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Charlotte B Wagner, Ken Boucher, Adrienne Nedved, Ivana N Micallef, Sanjal Desai, Elizabeth A Brem

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.
Elizabeth A Brem, Laurie H Sehn

Semin Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Tamer Othman, Michelle A Quan, Shiliang Zhang, Daria Gaut, Patricia A Young, Elizabeth A Brem

Clin Lymphoma Myeloma Leuk· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E Brammer, Tatyana A Feldman, Elizabeth A Brem

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
Benjamin J Lee, Yen Cao, Pongthep Vittayawacharin, Ghaydá É'Leima, Sherif Rezk, Elizabeth A Brem

Eur J Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinonasal lymphoma: A primer for otolaryngologists.
Benjamin F Bitner, Nyein Nyein Htun, Beverly Y Wang, Elizabeth A Brem, Edward C Kuan

Laryngoscope Investig Otolaryngol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Tamer Othman, Juan Penaloza, Shiliang Zhang, Claire E Daniel, Daria Gaut, Elizabeth A Brem

Clin Lymphoma Myeloma Leuk· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eponyms in Malignant Hematology.
Danielle Brazel, Priyanka Kumar, David J Benjamin, Elizabeth Brem

Cancer Treat Res Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eponyms in medical oncology.
Priyanka Kumar, Danielle Brazel, David J Benjamin, Elizabeth Brem

Cancer Treat Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
Elizabeth A Brem, Hongli Li, Anne W Beaven, Paolo F Caimi, Leandro Cerchietti

J Geriatr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Management of CLL in 2021.
Elizabeth A Brem, Susan O'Brien

JCO Oncol Pract· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is a BTKi or BCL2i preferable for first "novel" therapy in CLL? The case for BTKis.
Elizabeth A Brem, Susan O'Brien

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma.
Brandon M Lehrich, Arash Abiri, Khodayar Goshtasbi, Jack Birkenbeuel, Tyler M Yasaka, Elizabeth A Brem

Laryngoscope· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Just the facts: febrile neutropenia in the emergency department setting.
Brit Long, Elisha Targonsky, Elizabeth Brém

CJEM· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat.
Katelin Morrissette, Rachel Bridwell, Skyler Lentz, Elizabeth Brem, Karla Olmedo Gutierrez

J Emerg Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma.
Brandon M Lehrich, Khodayar Goshtasbi, Arash Abiri, Tyler M Yasaka, Peter Papagiannopoulos, Elizabeth A Brem

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Emergencies: Immune-Based Cancer Therapies and Complications.
Brit Long, Elizabeth Brém, Alex Koyfman

West J Emerg Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis